XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 27.13

+1.7%

Jan 13 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (3729)	9/13/1997 8:26:00 PM
From: nestegg	of 17367

As I'm trying to imply...get 'real' and back to Basics w/ XOMA comments. Hoping we get some Good PR and newer progress Info from the following San Francisco Medical Conferences: Infectious Diseases Society of America Sept. 13-16, 1997... San Francisco, CA Bob Bauer, Ph.D., Pharmacokinetics of BPI-derived peptides ÿ NMHCC: Immune Modulation for Transplantation & Autoimmune Diseases Sept. 17-19, 1997... San Francisco, CA Marvin R. Garovoy, M.D., A monoclonal antibody therapeutic in organ transplantation If anybody reading this is attending, please share a short synopsis in Summary about what was presented at above 2 Seminars?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next